Free Float 37,71 %
Shares Float 1,59 M
Shares Outstanding 4,21 M
Eucrates Biomedical Acquisition Corp.
Share · VGG3141W1068 · EUCR (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Eucrates Biomedical Acquisition Corp.
No Price
Share Float & Liquidity
Company Profile for Eucrates Biomedical Acquisition Corp. Share
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Company Data
Name Eucrates Biomedical Acquisition Corp.
Company Eucrates Biomedical Acquisition Corp.
Symbol EUCR
Primary Exchange 
NASDAQ
NASDAQ
ISIN VGG3141W1068
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Parag Phoolchand Saxena MBA, MS
Market Capitalization 42 Mio
Country United States of America
Currency USD
Employees -
Address 250 West 55th Street, 10019 New York City
IPO Date 2020-12-28
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | EUCR |
More Shares
Investors who hold Eucrates Biomedical Acquisition Corp. also have the following shares in their portfolio:
